AU
UK
CA
NZ
IND
US
CytomX Therapeutics, Inc. (NASDAQ:CTMX), an oncology-focused biopharmaceutical company, received an upgrade from Barclays research analysts, moving its rating to "strong-buy,". This marks the latest in a series of analyst actions on the stock.
Lam Research Corporation (NASDAQ:LRCX) reported results for the quarter ended June 29, 2025, showing sequential and year-on-year growth across revenue, earnings, and margins. Quarterly revenue reachedUS$5.171 billion, representing a 9.6% increase from the March quarter and a 33.6% rise compared to the same period …
Index Update
Baker Hughes (NASDAQ:BKR) had its price target increased by Capital One Financial, which lifted its objective from USD 49.00 to USD 53.00 in a report issued Tuesday. The firm maintained an “overweight” rating, with the new price objective implying a potential upside of 12.13% …
Biogen Inc. (Nasdaq: BIIB) announced that the European Commission (EC) has granted marketing authorization for ZURZUVAE® (zuranolone) for the treatment of post-partum depression (PPD) in adults following childbirth. The decision makes ZURZUVAE the first and only treatment specifically indicated for PPD in the European …
In a move that was largely anticipated by Wall Street, the U.S. Federal Reserve's Federal Open Market Committee (FOMC) announced a quarter-percentage-point cut to the federal funds rate on September 17, 2025. This brings the new target range to 4% to 4.25%. The decision …
Lloyds Banking Group and Broadcom Inc. (NASDAQ: AVGO) have announced an expansion of their multi-year technology partnership, focusing on infrastructure software and cloud solutions to support the bank’s ongoing digital transformation. The agreement extends the Group’s access to Broadcom’s software portfolio, including VMware Cloud …
On September 16, 2025, the Nasdaq Composite and S&P 500 registered record intraday highs but ended the day slightly lower, with the Nasdaq closing down about0.1%. Markets were largely driven by growing anticipation of aFederal Reserve interest rate cutand stronger-than-expected August retail sales, which …
ASML Holding N.V. (NASDAQ:ASML) had its "buy" rating reaffirmed by analysts at JPMorgan Chase & Co. in a report released Tuesday, according to MarketScreener. The semiconductor equipment manufacturer remains under close watch by the investment community as analyst targets adjust amid recent earnings results.
Please wait processing your request...